Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan
· Delayed Price · Currency is JPY 7,940.00
+495.00 (6.65%)
Apr 28, 2026, 3:30 PM JST
Chugai Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,067,359 | 13,565,544 | 11,516,953 | 8,789,053 | 5,540,406 | 6,141,311 | Upgrade
|
| Market Cap Growth | 19.81% | 17.79% | 31.04% | 58.64% | -9.79% | -32.11% | Upgrade
|
| Enterprise Value | 12,217,264 | 12,683,097 | 10,671,635 | 8,170,288 | 4,995,111 | 5,744,662 | Upgrade
|
| Last Close Price | 7940.00 | 8243.00 | 6763.31 | 5083.63 | 3150.63 | 3416.66 | Upgrade
|
| PE Ratio | 28.90 | 31.26 | 29.74 | 27.00 | 14.80 | 20.27 | Upgrade
|
| Forward PE | 25.47 | 29.02 | 29.26 | 26.55 | 18.61 | 22.33 | Upgrade
|
| PS Ratio | 10.12 | 10.78 | 9.84 | 7.91 | 4.40 | 6.14 | Upgrade
|
| PB Ratio | 6.85 | 6.70 | 6.06 | 5.41 | 3.89 | 5.17 | Upgrade
|
| P/TBV Ratio | 7.07 | 6.88 | 6.11 | 5.47 | 3.96 | 5.27 | Upgrade
|
| P/FCF Ratio | 34.87 | 43.76 | 29.00 | 26.01 | 30.53 | 28.74 | Upgrade
|
| P/OCF Ratio | 29.59 | 35.12 | 25.73 | 21.44 | 22.70 | 21.96 | Upgrade
|
| PEG Ratio | 1.67 | 3.16 | 4.20 | 23.02 | 4.08 | 2.37 | Upgrade
|
| EV/Sales Ratio | 9.46 | 10.08 | 9.12 | 7.35 | 3.97 | 5.75 | Upgrade
|
| EV/EBITDA Ratio | 18.95 | 20.09 | 18.60 | 17.35 | 8.85 | 12.69 | Upgrade
|
| EV/EBIT Ratio | 19.96 | 21.18 | 19.69 | 18.60 | 9.37 | 13.62 | Upgrade
|
| EV/FCF Ratio | 32.60 | 40.91 | 26.87 | 24.17 | 27.52 | 26.89 | Upgrade
|
| Debt / Equity Ratio | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.04 | 0.02 | 0.03 | 0.02 | 0.04 | Upgrade
|
| Debt / FCF Ratio | - | 0.08 | 0.03 | 0.04 | 0.08 | 0.08 | Upgrade
|
| Net Debt / Equity Ratio | -0.45 | -0.47 | -0.52 | -0.45 | -0.34 | -0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.33 | -1.51 | -1.72 | -1.54 | -0.87 | -1.01 | Upgrade
|
| Net Debt / FCF Ratio | -2.27 | -3.08 | -2.48 | -2.15 | -2.69 | -2.13 | Upgrade
|
| Asset Turnover | 0.59 | 0.54 | 0.56 | 0.59 | 0.74 | 0.72 | Upgrade
|
| Inventory Turnover | 1.41 | 1.41 | 1.32 | 1.46 | 1.90 | 1.72 | Upgrade
|
| Quick Ratio | 3.67 | 3.46 | 4.59 | 3.68 | 2.40 | 2.53 | Upgrade
|
| Current Ratio | 4.70 | 4.24 | 5.53 | 4.74 | 3.15 | 3.25 | Upgrade
|
| Return on Equity (ROE) | 23.71% | 22.10% | 21.96% | 21.34% | 28.67% | 27.95% | Upgrade
|
| Return on Assets (ROA) | 17.38% | 16.00% | 16.36% | 14.44% | 19.56% | 19.01% | Upgrade
|
| Return on Invested Capital (ROIC) | 41.79% | 43.74% | 42.57% | 35.09% | 45.09% | 45.33% | Upgrade
|
| Return on Capital Employed (ROCE) | 31.60% | 29.10% | 28.30% | 26.70% | 36.90% | 34.80% | Upgrade
|
| Earnings Yield | 3.46% | 3.20% | 3.36% | 3.70% | 6.76% | 4.93% | Upgrade
|
| FCF Yield | 2.87% | 2.28% | 3.45% | 3.84% | 3.28% | 3.48% | Upgrade
|
| Dividend Yield | 1.66% | 1.48% | 1.45% | 1.57% | 2.48% | 2.22% | Upgrade
|
| Payout Ratio | 99.07% | 68.99% | 34.40% | 40.43% | 36.91% | 32.56% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | Upgrade
|
| Total Shareholder Return | 1.77% | 1.47% | 1.44% | 1.56% | 2.47% | 2.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.